Skip to main navigation Skip to search Skip to main content

Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications

  • Veronica Pini*
  • , Virginie Mariot
  • , Julie Dumonceaux
  • , John Counsell
  • , Helen C. O’Neill
  • , Sarah Farmer
  • , Francesco Conti
  • , Francesco Muntoni*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

2 Downloads (Pure)

Abstract

Among the mutations arising in the DMD gene and causing Duchenne Muscular Dystrophy (DMD), 10–15% are multi-exon duplications. There are no current therapeutic approaches with the ability to excise large multi-exon duplications, leaving this patient cohort without mutation-specific treatment. Using CRISPR/Cas9 could provide a valid alternative to achieve targeted excision of genomic duplications of any size. Here we show that the expression of a single CRISPR/Cas9 nuclease targeting a genomic region within a DMD duplication can restore the production of wild-type dystrophin in vitro. We assessed the extent of dystrophin repair following both constitutive and transient nuclease expression by either transducing DMD patient-derived myoblasts with integrating lentiviral vectors or electroporating them with CRISPR/Cas9 expressing plasmids. Comparing genomic, transcript and protein data, we observed that both continuous and transient nuclease expression resulted in approximately 50% dystrophin protein restoration in treated myoblasts. Our data demonstrate that a high transient expression profile of Cas9 circumvents its requirement of continuous expression within the cell for targeting DMD duplications. This proof-of-concept study therefore helps progress towards a clinically relevant gene editing strategy for in vivo dystrophin restoration, by highlighting important considerations for optimizing future therapeutic approaches.

Original languageEnglish
Article number3756
Pages (from-to)1-13
Number of pages13
JournalScientific Reports
Volume12
Issue number1
DOIs
Publication statusPublished - Dec 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications'. Together they form a unique fingerprint.

Cite this